ALX ONCOLOGY HOLDINGS INC (ALXO) Stock Analyst Earnings Estimates
NASDAQ:ALXO - Nasdaq - US00166B1052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.07M | 4.8M 131.88% | 1.18M -75.42% | -100.00% | 18.53M | 61.166M 230.09% | 94.23M 54.06% | 163.22M 73.21% | 377.62M 131.36% | |||||||
| EBITDA YoY % growth | -13.25M | -18.75M -41.51% | -43.46M -131.79% | -81.802M -92.15% | -137.471M -52.20% | -128.234M -33.10% | -118.85M 16.57% | -81.743M 42.08% | -65.066M 20.40% | -54.713M 15.91% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.68M | -19.18M -40.20% | -43.66M -127.63% | -82.164M -91.39% | -136.116M -52.51% | -169.65M -33.40% | -145.484M 16.47% | -112.52M 20.76% | -88.109M 21.69% | -83.452M 5.29% | -99.948M -19.77% | -80.625M 19.33% | -62.726M 22.20% | -6.384M 89.82% | 169.76M 2,759.07% | |
| Operating Margin | -660.87% | -399.58% | -3,700.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -539.38% | -131.81% | -66.57% | -3.91% | 44.96% | |
| EPS YoY % growth | N/A | N/A | -4.48 | -2.01 54.02% | -3.25 -47.09% | -3.51 -23.76% | -2.81 30.67% | -1.82 30.04% | -1.29 29.35% | -0.94 26.98% | 0.17 118.48% | 2.32 1,235.29% | 5.22 125.55% | 8.43 61.33% | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.46 39.61% | -0.38 34.93% | -0.35 36.02% | -0.37 36.69% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -21.471M 48.35% | -16.412M 48.57% | -14.474M 51.33% | N/A |
| EBIT Q2Q % growth | -23.272M 44.59% | -20.265M 37.77% | -18.895M 38.28% | -25.602M 19.54% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.58 18.31% | -0.47 | -0.11 | -22.55% |
| Q4 2024 Q2Q % growth | -0.55 40.86% | -0.68 | 0.13 | 19.52% |
| Q3 2024 Q2Q % growth | -0.58 53.23% | -0.80 | 0.22 | 27.10% |
| Q2 2024 Q2Q % growth | -0.76 9.52% | -0.79 | 0.03 | 3.65% |
| Q1 2024 Q2Q % growth | -0.71 4.05% | -0.85 | 0.14 | 16.80% |
| Q4 2023 Q2Q % growth | -0.93 -24.00% | -0.86 | -0.07 | -8.36% |
| Q3 2023 Q2Q % growth | -1.24 -42.53% | -0.89 | -0.35 | -39.73% |
| Q2 2023 Q2Q % growth | -0.84 -3.70% | -0.90 | 0.06 | 6.42% |
| Q1 2023 Q2Q % growth | -0.74 -23.33% | -0.82 | 0.08 | 9.52% |
| Q4 2022 Q2Q % growth | -0.75 -7.14% | -0.90 | 0.15 | 17.02% |
| Q3 2022 Q2Q % growth | -0.87 -42.62% | -0.79 | -0.08 | -10.69% |
| Q2 2022 Q2Q % growth | -0.81 -102.50% | -0.65 | -0.16 | -25.35% |
| Q1 2022 Q2Q % growth | -0.60 -71.43% | -0.73 | 0.13 | 17.40% |
| Q4 2021 Q2Q % growth | -0.70 -45.83% | -0.63 | -0.07 | -10.84% |
| Q3 2021 Q2Q % growth | -0.61 -69.44% | -0.49 | -0.12 | -25.73% |
| Q2 2021 Q2Q % growth | -0.40 88.17% | -0.44 | 0.04 | 8.37% |
| Q1 2021 Q2Q % growth | -0.35 -12.90% | -0.42 | 0.07 | 16.67% |
| Q4 2020 Q2Q % growth | -0.48 | -0.36 | -0.12 | -33.06% |
| Q3 2020 Q2Q % growth | -0.36 | -0.37 | 0.01 | 2.07% |
| Q2 2020 Q2Q % growth | -3.38 | -0.34 | -3.04 | -895.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | 168.3K | -168.3K | -100.00% |
| Q4 2020 Q2Q % growth | -100.00% | 64.872K | -64.872K | -100.00% |
| Q3 2020 Q2Q % growth | -100.00% | 578.003K | -578.003K | -100.00% |
| Q2 2020 Q2Q % growth | 530K -59.23% | 765K | -235K | -30.72% |
| Q1 2020 Q2Q % growth | 660K -35.92% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.69% | 0% | -4.17% |
| Revenue | N/A | N/A | N/A | N/A |